Novartis at ASH

Latest resources and news surrounding Novartis data featured at the 63nd American Society of Hematology Annual Meeting (ASH).

Nov 29, 2021

Press release

New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio

Redefining what it means to live with blood disorders:

AddToAny buttons

Share Tweet Share Whatsapp Linkedin Email

Printable Links Block (Content)